Cadmium coordinates up-regulation of cytoprotective genes and protection agains metal toxicity by inhibiting the ubiquitination of Nrf2 and disrupting the Nrf2/Keap1 complex.
Authors
He-X; Lin-GX; Chen-MG; Ma-Q
Source
Ubiquitin and signaling, Keystone Symposia on Molecular and Cellular Biology, February 4-9, 2007, Big Sky, Montana, 2007 Book of Abstracts. Schulman BA, Hunter T, Hochstrasser MW, Joazeiro CAP, eds. Silverthorne, CO: Keystone Symposia, 2007 Feb; :57
Transcription factor Nrf2 is a key regulator of genes encoding phase II detoxification enzymes and antioxidant proteins in response to environmental chemical insults. Under homeostatic conditions, Nrf2 is rapidly degradated through a Keap1-dependent, ubiquitin-26S proteasome pathway. Cadmium (Cd) is a major occupational/environmental toxic metal element and a proven human carcinogen. Exposure to Cd can cause a wide range of toxicity and disease in humans. The molecular mechanism of Cd action is currently unclear. We reported here that Cd induces cytoprotective genes NAD(P)H-quinone oxidoreductase I (Nq01) and heme oxygenase I (Ho-1) via the Nrf2/Keap1 pathway. Genetic experiments using mouse embryonic fibroblast (MEF) cells derived from wild type or Nrf2 knockout mice revealed that the cells lacking Nrf2 exhibited markedly increased production of ROS and sensitivity to Cd cytotoxicity. In MEF cells with wild type Nrf2 and mouse hepa 1c1c7 cells, Cd increased the Nrf2 protein level but not the Nrf2 mRNA level dose-dependently. Cd stabilized the Nrf2 protein by inhibiting the Keap1/CuI3dependent ubiquitination and 26S proteasomal turnover of Nrf2. Cd did not affect the protein levels of Keap1, which is a repressor of the cytoplasmic Nrf2, or Cul-3, an E3 ligase involved in the proteasomal degradation of Nrf2. Using cell fractionation and immunoprecipitation, we further demonstrated that Nrf2 and Keap1 were both detected in the cytoplasm and nucleus. Both proteins were ubiquitinated in the cytoplasm. Cd treatment reduced the ubiquitination of Nrf2, increased the nuclear accumulation of Nrf2, and disrupted the Nrf2/Keap1 complex in the nucleus. Chromatin immunoprecipitation (ChiP) assay revealed that Cd substantially increased the ARE occupancy of Nrf2 but not keap1, indicating Keap1 may recycle from the nucleus to the cytoplasm. These results provide a new model of Nrf2 activation by toxic metals.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.